News Announcement

Kappac Pharma: Submission Of Audited Financial Result For Quarter And Half-Year Ended September 30,2018 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations, 2015

In terms of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of
. India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Listing
Regulations), we wish to inform you that the Unaudited Financial Results (Standalone) of the
Company for the Quarter and Half-Year ended September 30, 2018 were approved by the
Board of Directors of the Company at its meeting held today.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.